EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
It is an insulin sensitizer, but unfortunately has been seen to have bad effect on urinary bladder in long term use. Cannot the harmful effect producing fraction of molecule be silenced in some way, so that a good drug will remain in the armour of the physicians?
EGR1 expression: a calcium and ERK1/2 mediated PPAR?-independent event involved in the antiproliferative effect of 15-deoxy-?12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
Pops
Newest Clips
Latest Comments
Most Pops
Print
Save
Turn on live update